Dr. Peter Halfmann, PhD, is a research associate professor at the University of Wisconsin– Madison who oversees the screening and characterization of antiviral compounds against filoviruses (Ebola and Marburg viruses) utilizing a range of cell-based assays that he developed. Additionally, he is a visiting scientist at NIAID’s Rocky Mountain Laboratory where he has biosafety level-4 access for research with authentic filoviruses.
